Nu Skin Enterprises (NUS) 10-Q3 May 232023 Q1 Quarterly reportFinancial data

Company Profile

Document and Entity Information

Document and Entity Information - shares	3 Months Ended
Document and Entity Information - shares	Mar. 31, 2023	Apr. 30, 2023
Cover [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Quarterly Report	true
Document Period End Date	Mar. 31, 2023
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	Q1
Document Transition Report	false
Entity File Number	001-12421
Entity Registrant Name	NU SKIN ENTERPRISES, INC.
Entity Central Index Key	0001021561
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	87-0565309
Entity Address, Address Line One	75 West Center Street
Entity Address, City or Town	Provo
Entity Address, State or Province	UT
Entity Address, Postal Zip Code	84601
City Area Code	801
Local Phone Number	345-1000
Title of 12(b) Security	Class A Common Stock, $.001 par value
Trading Symbol	NUS
Security Exchange Name	NYSE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		49,905,275

Consolidated Balance Sheets (Un

Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Current assets:
Cash and cash equivalents	$ 229,941	$ 264,725
Current investments	16,774	13,784
Accounts receivable, net	60,008	47,360
Inventories, net	366,537	346,183
Prepaid expenses and other	100,302	87,816
Total current assets	773,562	759,868
Property and equipment, net	437,986	444,806
Operating lease right-of-use assets	98,683	98,734
Goodwill	206,432	206,432
Other intangible assets, net	64,711	66,701
Other assets	243,271	244,429
Total assets	1,824,645	1,820,970
Current liabilities:
Accounts payable	49,494	53,963
Accrued expenses	275,774	280,280
Current portion of long-term debt	47,500	25,000
Total current liabilities	372,768	359,243
Operating lease liabilities	78,776	76,540
Long-term debt	372,609	377,466
Other liabilities	107,522	110,425
Total liabilities	931,675	923,674
Commitments and contingencies (Notes 5 and 11)
Stockholders' equity:
Class A common stock - 500 million shares authorized, $0.001 par value, 90.6 million shares issued	91	91
Additional paid-in capital	611,483	613,278
Treasury stock, at cost - 40.7 million and 41.1 million shares	(1,559,080)	(1,569,061)
Accumulated other comprehensive loss	(91,005)	(86,509)
Retained earnings	1,931,481	1,939,497
Total stockholders' equity	892,970	897,296
Total liabilities and stockholders' equity	$ 1,824,645	$ 1,820,970

Consolidated Balance Sheets (_2

Consolidated Balance Sheets (Unaudited) (Parenthetical) - $ / shares shares in Millions	Mar. 31, 2023	Dec. 31, 2022
Stockholders' equity:
Common stock, shares authorized (in shares)	500	500
Common stock, par value (in dollars per share)	$ 0.001	$ 0.001
Common stock, shares issued (in shares)	90.6	90.6
Treasury stock (in shares)	40.7	41.1

Consolidated Statements of Inco

Consolidated Statements of Income (Unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Consolidated Statements of Income [Abstract]
Revenue	$ 481,462	$ 604,899
Cost of sales	133,588	161,499
Gross profit	347,874	443,400
Operating expenses:
Selling expenses	188,124	242,699
General and administrative expenses	133,899	148,556
Restructuring and impairment expenses	9,787	0
Total operating expenses	331,810	391,255
Operating income	16,064	52,145
Other income (expense), net	(1,476)	(1,453)
Income before provision for income taxes	14,588	50,692
Provision for income taxes	3,212	11,976
Net income	$ 11,376	$ 38,716
Net income per share (Note 6):
Basic (in dollars per share)	$ 0.23	$ 0.77
Diluted (in dollars per share)	$ 0.23	$ 0.76
Weighted-average common shares outstanding:
Basic (in shares)	49,644	49,991
Diluted (in shares)	50,058	51,066

Consolidated Statements of Comp

Consolidated Statements of Comprehensive Income (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Consolidated Statements of Comprehensive Income [Abstract]
Net income	$ 11,376	$ 38,716
Other comprehensive (loss) income, net of tax:
Foreign currency translation adjustment, net of taxes of $(68) and $(7) for the three months ended March 31, 2023 and 2022, respectively	(2,139)	(1,960)
Net unrealized gains/(losses) on cash flow hedges, net of taxes of $175 and $(1,743) for the three months ended March 31, 2023 and 2022, respectively	(635)	6,314
Reclassification adjustment for realized losses/(gains) in current earnings, net of taxes of $475 and $(4) for the three months ended March 31, 2023 and 2022, respectively	(1,722)	14
Other comprehensive (loss) income, net of tax	(4,496)	4,368
Comprehensive income	$ 6,880	$ 43,084

Consolidated Statements of Co_2

Consolidated Statements of Comprehensive Income (Unaudited) (Parenthetical) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Other comprehensive (loss) income, net of tax:
Foreign currency translation adjustment, tax	$ (68)	$ (7)
Net unrealized gains/(losses) on foreign currency cash flow hedges, tax	175	(1,743)
Reclassification adjustment for realized losses/(gains) in current earnings on cash flow hedges, tax	$ 475	$ (4)

Consolidated Statements of Stoc

Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($) $ in Thousands	Common Stock [Member] Class A [Member]	Additional Paid-in Capital [Member]	Treasury Stock [Member]	Accumulated Other Comprehensive Loss [Member]	Retained Earnings [Member]	Total
Balance at beginning of period at Dec. 31, 2021	$ 91	$ 601,703	$ (1,526,860)	$ (73,896)	$ 1,911,734	$ 912,772
Stockholders' Equity [Roll Forward]
Net income	0	0	0	0	38,716	38,716
Other comprehensive income (loss), net of tax	0	0	0	4,368	0	4,368
Repurchase of Class A common stock (Note 6)	0	0	(10,006)	0	0	(10,006)
Exercise of employee stock options/vesting of stock awards	0	(6,572)	10,088	0	0	3,516
Stock-based compensation	0	4,127	0	0	0	4,127
Cash dividends	0	0	0	0	(19,293)	(19,293)
Balance at end of period at Mar. 31, 2022	91	599,258	(1,526,778)	(69,528)	1,931,157	934,200
Balance at beginning of period at Dec. 31, 2022	91	613,278	(1,569,061)	(86,509)	1,939,497	897,296
Stockholders' Equity [Roll Forward]
Net income	0	0	0	0	11,376	11,376
Other comprehensive income (loss), net of tax	0	0	0	(4,496)	0	(4,496)
Repurchase of Class A common stock (Note 6)	0	0	0	0	0	0
Exercise of employee stock options/vesting of stock awards	0	(5,797)	9,981	0	0	4,184
Stock-based compensation	0	4,002	0	0	0	4,002
Cash dividends	0	0	0	0	(19,392)	(19,392)
Balance at end of period at Mar. 31, 2023	$ 91	$ 611,483	$ (1,559,080)	$ (91,005)	$ 1,931,481	$ 892,970

Consolidated Statements of St_2

Consolidated Statements of Stockholders' Equity (Unaudited) (Parenthetical) - shares shares in Millions	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Stockholders' Equity [Roll Forward]
Exercise of employee stock options (in shares)	0.4	0.4

Consolidated Statements of Cash

Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Cash flows from operating activities:
Net income	$ 11,376	$ 38,716
Adjustments to reconcile net income to cash flows from operating activities:
Depreciation and amortization	16,983	17,130
Non-cash lease expense	8,566	10,581
Stock-based compensation	4,002	4,127
Foreign currency (gains)/losses	(2,102)	370
(Gain)/loss on disposal of assets	(17)	517
Deferred taxes	(72)	3,292
Changes in operating assets and liabilities:
Accounts receivable, net	(15,336)	(12,463)
Inventories, net	(19,734)	17,212
Prepaid expenses and other	(12,895)	(18,110)
Other assets	(864)	941
Accounts payable	(4,495)	(5,663)
Accrued expenses	(4,129)	(40,270)
Other liabilities	(3,360)	(8,839)
Net cash (used in) / provided by operating activities	(22,077)	7,541
Cash flows from investing activities:
Purchases of property and equipment	(11,487)	(10,279)
Proceeds on investment sales	4,986	4,076
Purchases of investments	(8,195)	(3,930)
Net cash used in investing activities	(14,696)	(10,133)
Cash flows from financing activities:
Exercise of employee stock options and taxes paid related to the net shares settlement of stock awards	4,184	3,516
Payment of cash dividends	(19,392)	(19,293)
Repurchases of shares of common stock	0	(10,006)
Finance lease principal payments	(912)	(476)
Payments of debt	(2,500)	(7,500)
Proceeds from debt	20,000	0
Net cash provided by/(used in) financing activities	1,380	(33,759)
Effect of exchange rate changes on cash	609	(1,026)
Net decrease in cash and cash equivalents	(34,784)	(37,377)
Cash and cash equivalents, beginning of period	264,725	339,593
Cash and cash equivalents, end of period	$ 229,941	$ 302,216

The Company

The Company	3 Months Ended
The Company	Mar. 31, 2023
The Company [Abstract]
The Company	1. The Company Nu Skin Enterprises, Inc. (the “Company”) is a holding company, with Nu Skin, being the primary operating unit. Nu Skin develops and distributes premium-quality, innovative beauty and wellness products that are sold worldwide under the Nu Skin, Pharmanex and ageLOC brands and a small number of other products and services. The Company reports revenue from nine segments, consisting of its seven geographic Nu Skin segments —Americas,

Summary of Significant Accounti

Summary of Significant Accounting Policies	3 Months Ended
Summary of Significant Accounting Policies	Mar. 31, 2023
Summary of Significant Accounting Policies [Abstract]
Summary of Significant Accounting Policies	2. Summary of Significant Accounting Policies The accompanying unaudited consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”) The unaudited consolidated financial statements include the accounts of the Company and its Subsidiaries. All significant intercompany accounts and transactions are eliminated in consolidation. In the opinion of management, the accompanying unaudited consolidated financial statements contain all adjustments, consisting of normal recurring adjustments, considered necessary for a fair statement of the Company’s financial information as of March and for the -month periods ended March and The results of operations of any interim period are not necessarily indicative of the results of operations to be expected for the fiscal year. The consolidated balance sheet as of December has been prepared using information from the audited financial statements at that date. For further information, refer to the consolidated financial statements and accompanying footnotes included in the Company’s Annual Report on Form -K for the year ended December Accounting Pronouncements In March 2020 Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting, Company’s debt transitioned to the Secured Overnight Financing Rate (“SOFR”) Inventory Inventories consist of the following (U.S. dollars in thousands): March 31, 2023 December 31, 2022 Raw materials $ 175,579 $ 163,797 Finished goods 190,958 182,386 Total Inventory, net $ 366,537 $ 346,183 Revenue Recognition Contract Liabilities – Customer Loyalty Programs Contract liabilities, recorded as deferred revenue within the accrued expenses line in the consolidated balance sheets, include loyalty point program deferrals with certain customers which are accounted for as a reduction in the transaction price and are generally recognized as points are redeemed for additional products. The balance of deferred revenue related to contract liabilities as of March and December was and , respectively. The contract liabilities impact to revenue for the -month periods ended March and was an increase of

Goodwill

Goodwill	3 Months Ended
Goodwill	Mar. 31, 2023
Goodwill [Abstract]
Goodwill	3. Goodwill The Company’s reporting units for goodwill are its operating segments, which are also its reportable segments. The Company completed the annual goodwill and indefinite-lived intangible asset impairment testing as of October 1, 2022, and concluded that the fair value of the reporting units were determined to be in excess of its carrying amounts and no goodwill impairment charge was required. As of the October 1, 2022 testing date, the fair value of the Manufacturing reporting unit was estimated to be approximately 8% in excess of its carrying amount, and therefore the reporting unit is considered to be at risk of future impairment. The Manufacturing reporting unit's fair value remains sensitive to significant unfavorable changes in revenue, gross margin and discount rates that could negatively impact future analyses. Fair value determinations require considerable judgment and are sensitive to changes in underlying assumptions and factors. As a result, there can be no assurance that the estimates and assumptions made for purposes of the goodwill impairment tests will prove to be an accurate prediction of the future. Although the Manufacturing reporting unit showed strong revenue growth in fiscal year 2020 and 2021, the fair value of the reporting unit in 2022 was negatively impacted by an increase in the discount rate due to the current interest rate environment, and lower near-term revenue projections. Current projections used for the Manufacturing reporting unit reflect revenue growth attributable to the continued expansion of capacity, continued intercompany sales to Nu Skin, and the recent acquisition of new customers. While historical performance and current expectations have resulted in fair values of the Manufacturing reporting unit in excess of carrying values, if the assumptions are not realized an impairment charge may be recorded in the future. The following table presents goodwill allocated to the Company’s reportable segments for the periods ended and December 31, 2022 (U.S. dollars in thousands): March 31, 2023 December 31, 2022 Nu Skin Americas $ 9,449 $ 9,449 South Korea 29,261 29,261 Mainland China 32,179 32,179 Southeast Asia/Pacific 18,537 18,537 Japan 16,019 16,019 EMEA 2,875 2,875 Hong Kong/Taiwan 6,634 6,634 Rhyz Investments Manufacturing 78,875 78,875 Rhyz Other 12,603 12,603 Total $ 206,432 $ 206,432

Debt

Debt	3 Months Ended
Debt	Mar. 31, 2023
Debt [Abstract]
Debt	4. Debt Credit Agreement On June 14, 2022, the Company entered into an Amended and Restated Credit Agreement (the “Credit Agreement”) with several financial institutions as lenders and Bank of America, N.A., as administrative agent, which amended and restated the 2018 Credit Agreement. The Credit Agreement provides for a $400 million term loan facility and a $500 million revolving credit facility, each with a term of five years. Both facilities bear interest at the SOFR, plus a margin based on the Company’s consolidated leverage ratio. Commitment fees payable under the Credit Agreement are also based on the consolidated leverage ratio as defined in the Credit Agreement and range from 0.175% to 0.30% on the unused portion of the total lender commitments then in effect. The term loan facility amortizes in quarterly installments in amounts resulting in an annual amortization of 2.5% during the first year and 5.0% during the second, third, fourth and fifth years after the closing date of the Credit Agreement, with the remainder payable at final maturity. The Credit Agreement is guaranteed by certain of the Company’s domestic subsidiaries and collateralized by assets of such subsidiaries, including a pledge of 65% of the capital stock of certain foreign subsidiaries. The Credit Agreement requires the Company to maintain a consolidated leverage ratio not exceeding 2.75 to 1.00 and a consolidated interest coverage ratio of no less than 3.00 to 1.00. As of March 31, 2023, the Company was in compliance with all covenants under the Credit Agreement. The following table summarizes the Company’s debt facilities as of March 31, 2023 and December 31, 2022: Facility or Arrangement Original Principal Amount Balance as of March 31, 2023 (1)(2) Balance as of December 31, 2022 (1)(2) Interest Rate Repayment Terms Credit Agreement term loan facility $400.0 million $392.5 million $395.0 million Variable 21% of the principal amount is payable Credit Agreement revolving credit facility $30.0 million $10.0 million Variable Revolving line of credit expires June 14, 2027. (1) As of March 31, 2023 and December 31, 2022, the current portion of the Company’s debt (i.e., becoming due in the next 12 months) included $17.5 million and $15.0 million, respectively, of the balance of its term loan under the Credit Agreement. (2) The carrying value of the debt reflects the amounts stated in the above table, less debt issuance costs of $2.4 million and $ million as of and December 31, 2022, respectively, related to the Credit Agreement, which are not reflected in this table.

Leases

Leases	3 Months Ended
Leases	Mar. 31, 2023
Leases [Abstract]
Leases	5. Leases As of . The components of lease expense were as follows (U.S. dollars in thousands): Three Months Ended March 31 2023 2022 Operating lease expense Operating lease cost $ 8,161 $ 10,439 Variable lease cost 1,075 1,157 Short-term lease cost — 30 Finance lease expense Amortization of right-of-use assets 1,000 556 Interest on lease liabilities 134 66 Total lease expense $ 10,370 $ 12,248 Supplemental cash flow information related to leases was as follows (U.S. dollars in thousands): Three March 31 2023 2022 Operating cash outflow from operating leases $ 8,150 $ 10,405 Operating cash outflow from finance leases $ 132 $ 68 Financing cash outflow from finance leases $ 912 $ 476 Right-of-use assets obtained in exchange for operating lease obligations $ 7,981 $ 23,730 Right-of-use assets obtained in exchange for finance lease obligations $ 520 $ — Maturities of lease liabilities were as follows (U.S. dollars in thousands): Year Ending December 31 Operating Leases Finance Leases 2023 $ 18,542 $ 2,875 2024 20,249 3,474 2025 14,916 3,400 2026 10,241 3,305 2027 7,885 2,953 Thereafter 43,851 — Total 115,684 16,007 Less: Finance charges 15,200 1,269 Total principal liability $ 100,484 $ 14,738 The Company has additional lease liabilities of $ million which have not yet commenced as of , and as such, have not been recognized on the consolidated balance sheets.

Capital Stock

Capital Stock	3 Months Ended
Capital Stock	Mar. 31, 2023
Capital Stock [Abstract]
Capital Stock	6. Capital Stock Net income per share Net income per share is computed based on the weighted-average number of common shares outstanding during the periods presented. Additionally, diluted earnings per share data gives effect to all potentially dilutive common shares that were outstanding during the periods presented. For the three-month periods ended March 31, 2023 and 2022, the only dilutive common shares outstanding relate to the Company’s outstanding stock awards and options. For the three-month periods ended March 31, 2023 and 2022, stock options of 0.1 million and 0.1 million, respectively, were excluded from the calculation of diluted earnings per share because they were anti-dilutive. Dividends In February 2023 April 2023 Repurchase of common stock During the three-month periods ended March 31, 2023 and 2022, the Company repurchased zero and 0.2 million shares of its Class A common stock under its stock repurchase plans for zero and $10.0 million, respectively. As of March 31, 2023, $175.4 million was available for repurchases under the Company’s stock repurchase plan.

Fair Value and Equity Investmen

Fair Value and Equity Investments	3 Months Ended
Fair Value and Equity Investments	Mar. 31, 2023
Fair Value and Equity Investments [Abstract]
Fair Value and Equity Investments	7. Fair Value and Equity Investments Fair Value The carrying value of financial instruments including cash and cash equivalents, accounts receivable and accounts payable approximates fair values due to the short-term nature of these instruments. The carrying value of debt approximates fair value due to the variable 30-day interest rate. Fair value estimates are made at a specific point in time, based on relevant market information. The FASB Codification defines fair value as the price that would be received to sell an asset or paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants at the measurement date. On a quarterly basis, the Company measures at fair value certain financial assets, including cash equivalents. Accounting standards specify a hierarchy of valuation techniques based on whether the inputs to those valuation techniques are observable or unobservable. Observable inputs reflect data obtained from independent sources, while unobservable inputs reflect the Company’s market assumptions. These two types of inputs have created the following fair-value hierarchy: ■ Level 1 – quoted prices in active markets for identical assets or liabilities; ■ Level 2 – inputs, other than the quoted prices in active markets, that are observable either directly or indirectly; and ■ Level 3 – unobservable inputs based on the Company’s own assumptions. Accounting standards permit companies, at their option, to measure certain financial instruments and other eligible items at fair value. The Company has elected not to apply the fair value option to existing eligible items beyond what is required by US GAAP. The following tables present the fair value hierarchy for those assets and liabilities measured at fair value on a recurring basis (U.S. dollars in thousands): Fair Value at March 31, 2023 Level 1 Level 2 Level 3 Total Financial assets (liabilities): Cash equivalents and current investments $ 46,632 $ — $ — $ 46,632 Derivative financial instruments asset — 16,731 — 16,731 Life insurance contracts — — 42,053 42,053 Contingent consideration — — (6,271 ) (6,271 ) Total $ 46,632 $ 16,731 $ 35,782 $ 99,145 Fair Value at December 31, 2022 Level 1 Level 2 Level 3 Total Financial assets (liabilities): Cash equivalents and current investments $ 55,356 $ — $ — $ 55,356 Derivative financial instruments asset — 19,738 — 19,738 Life insurance contracts — — 40,055 40,055 Contingent consideration — — (6,364 ) (6,364 ) Total $ 55,356 $ 19,738 $ 33,691 $ 108,785 The following table provides a summary of changes in fair value of the Company’s Level 3 life insurance contracts (U.S. dollars in thousands): 2023 2022 Beginning balance at January 1 $ 40,055 $ 49,851 Actual return on plan assets 1,998 (3,401 ) Ending balance at March 31 $ 42,053 $ 46,450 Life insurance contracts: The following table provides a summary of changes in fair value of the Company’s Level 3 contingent consideration (U.S. dollars in thousands): 2023 2022 Beginning balance at January 1 $ (6,364 ) $ (10,341 ) Changes in fair value of contingent consideration 93 115 Ending balance at March 31 $ (6,271 ) $ (10,226 ) Contingent consideration: Equity Investments The Company maintains equity investments in companies which are accounted for under the measurement alternative described in ASC - - - for equity securities that lack readily determinable fair values. The carrying amount of equity securities held by the Company without readily determinable fair values was at each of March 31, 2023 and December During the months ended September the Company recognized upward fair value adjustments, based on the valuation of additional equity issued by the investee which was deemed to be an observable transaction of a similar investment under ASC was recorded within Other income (expense), net on the Consolidated Statement of Income. The upward fair value adjustment represents a nonrecurring fair value measurement based on observable price changes and is classified as a Level fair value measurement.

Income Taxes

Income Taxes	3 Months Ended
Income Taxes	Mar. 31, 2023
Income Taxes [Abstract]
Income Taxes	8. Income Taxes Provision for income taxes for the first quarter of 2023 was $3.2 million, compared to $12.0 million for the prior-year period. The effective tax rates for the first quarter 2023 was 22.0% of pre-tax income compared to 23.6% in the prior-year period. The Company accounts for income taxes in accordance with ASC Topic 740 “Income Taxes.” These standards establish financial accounting and reporting standards for the effects of income taxes that result from an enterprise’s activities during the current and preceding years. The Company takes an asset and liability approach for financial accounting and reporting of income taxes. The Company pays income taxes in many foreign jurisdictions based on the profits realized in those jurisdictions, which can be significantly impacted by terms of intercompany transactions between the Company and its foreign affiliates. Deferred tax assets and liabilities are created in this process. The Company has netted these deferred tax assets and deferred tax liabilities by jurisdiction. Valuation allowances are established when necessary to reduce deferred tax assets to the amounts expected to be ultimately realized. The Company had net deferred tax assets of $91.8 million and $89.3 million as of March 31, 2023 and December 31, 2022, respectively. The Company evaluates its indefinite reinvestment assertions with respect to foreign earnings for each quarter. For all foreign earnings, the Company accrues the applicable foreign income taxes. For the earnings that have been indefinitely reinvested, the Company does not accrue foreign withholding taxes. Undistributed earnings that the Company has indefinitely reinvested, for which no foreign withholding taxes have been provided, aggregate to $60.0 million as of December 31, 2022. If the amount designated as indefinitely reinvested as of December 31, 2022 was repatriated to the United States, the amount of incremental taxes would be approximately $6.0 million. The Company intends to utilize the indefinitely reinvested offshore earnings to fund foreign investments, specifically capital expenditures. The Company files income tax returns in the U.S. federal jurisdiction, and in various state and foreign jurisdictions. In 2009, the Company entered into a voluntary program with the IRS called Compliance Assurance Process (“CAP”). The objective of CAP is to contemporaneously work with the IRS to achieve federal tax compliance and resolve all or most of the issues prior to filing of the tax return. As of December 31, 2022, tax years through 2020 have been audited and are effectively closed to further examination. For tax years 2021 and 2023, the Company is in the Bridge phase of the CAP program, pursuant to which the IRS will not accept disclosures, will not conduct reviews and will not provide letters of assurance for the Bridge years. There are limited circumstances that tax years in the Bridge phase will be opened for examination. For tax year 2022, the Company has accepted an invitation to participate in the IRS’s new pilot program, Bridge Plus. The Company may elect to continue participating in CAP for future tax years; the Company may withdraw from the program at any time. With a few exceptions, the Company is no longer subject to state and local income tax examination by tax authorities for the years before 2019. Foreign jurisdictions have varying lengths of statues of limitations for income tax examinations. Some statutes are as short as three years and in certain markets may be as long as ten years. The Company is currently under examination in certain foreign jurisdictions; however, the outcomes of those reviews are not yet determinable. The Company’s unrecognized tax benefits relate to multiple jurisdictions. Due to potential increases in unrecognized tax benefits from the multiple jurisdictions in which the Company operates, as well as the expiration of various statutes of limitations, it is reasonably possible that the Company’s gross unrecognized tax benefits, net of foreign currency adjustments, may increase in the next 12 months by approximately $3.0 to $4.0 million.

Derivatives and Hedging Activit

Derivatives and Hedging Activities	3 Months Ended
Derivatives and Hedging Activities	Mar. 31, 2023
Derivatives and Hedging Activities [Abstract]
Derivatives and Hedging Activities	9. Derivatives and Hedging Activities Risk Management Objective of Using Derivatives The Company is exposed to certain risks arising from both its business operations and economic conditions. The Company principally manages its exposures to a wide variety of business and operational risks through management of its core business activities. The Company manages economic risks, including interest rate, liquidity, and credit risk primarily by managing the amount, sources, and duration of its assets and liabilities and the use of derivative financial instruments. Specifically, the Company enters into derivative financial instruments to manage exposures that arise from business activities that result in the receipt or payment of future known and uncertain cash amounts, the value of which are determined by interest rates. The Company’s derivative financial instruments are used to manage differences in the amount, timing, and duration of the Company’s known or expected cash receipts and its known or expected cash payments principally related to the Company’s borrowings. Cash Flow Hedges of Interest Rate Risk The Company’s objectives in using interest rate derivatives are to add stability to interest expense and to manage its exposure to interest rate movements. To accomplish this objective, the Company primarily uses interest rate swaps as part of its interest rate risk management strategy. Interest rate swaps designated as cash flow hedges involve the receipt of variable-rate amounts from a counterparty in exchange for the Company making fixed-rate payments over the life of the agreements without exchange of the underlying notional amount. During 2023, such derivatives were used to hedge the variable cash flows associated with existing variable-rate debt. For derivatives designated and that qualify as cash flow hedges of interest rate risk, the gain or loss on the derivative is recorded in Accumulated Other Comprehensive Income and subsequently reclassified into interest expense/income in the same period(s) during which the hedged transaction affects earnings. Amounts reported in accumulated other comprehensive income related to derivatives will be reclassified to interest expense/income as interest payments are made/received on the Company’s variable-rate debt. During the next twelve months, the Company estimates that an additional $8.8 million will be reclassified as a reduction to interest expense. As of March 31, 2023 and December 31, 2022, the Company had four outstanding interest rate derivatives that were designated as cash flow hedges of interest rate risk with a total notional amount of $200 million. Fair Values of Derivative Instruments on the Balance Sheet The table below presents the fair value of the Company’s derivative financial instruments as well as their classification on the Balance Sheet: Fair Values of Derivative Instruments Derivatives in Cash flow Hedging Relationships: Balance Sheet Location March 31, 2023 December 31, 2022 Interest Rate Swap - Asset Prepaid expenses and other $ 8,814 $ 9,156 Interest Rate Swap - Asset Other assets $ 7,917 $ 10,582 Effect of Cash Flow Hedge Accounting on Accumulated Other Comprehensive Loss The tables below present the effect of cash flow hedge accounting on Accumulated Other Comprehensive Loss. Amount of Gain (Loss) Recognized in OCI on Derivatives Three Months Ended Derivatives in Cash flow March 31, Hedging Relationships: 2023 2022 Interest Rate Swaps $ (810 ) $ 8,057 Amount of Gain (Loss) Reclassified from Accumulated Other Comprehensive Loss into Income Three Months Ended Derivatives in Cash flow Income Statement March 31, Hedging Relationships: Location 2023 2022 Interest Rate Swaps Other income (expense), net $ 2,197 $ (18 )

Segment Information

Segment Information	3 Months Ended
Segment Information	Mar. 31, 2023
Segment Information [Abstract]
Segment Information	10. Segment Information The Company reports revenue from nine segments, consisting of its seven geographic Nu Skin segments— Americas, Mainland China, Southeast Asia/Pacific, South Korea, Japan, EMEA, and Hong Kong/Taiwan Company’s Profitability by segment as determined under US GAAP is driven primarily by the Company’s transfer pricing policies. Segment contribution, which is the Company’s segment profitability metric presented in the table below, excludes certain intercompany charges, specifically royalties, license fees, transfer pricing, discrete charges and other miscellaneous items. These charges have been included in Corporate and other expenses. Corporate and other expenses also include costs related to the Company’s executive and administrative offices, information technology, research and development, and marketing and supply chain functions not recorded at the segment level. In the first quarter of 2023, the Company adjusted how it allocates certain corporate overhead costs to the segments. The prior-year segment information has been recast to comply with current presentation. Consolidated financial information is not affected. The accounting policies of the segments are the same as those described in Note 2 – Summary of Significant Accounting Policies. The Company evaluates the performance of its segments based on revenue and segment contribution. Each segment records direct expenses related to its employees and its operations. Summarized financial information for the Company’s reportable segments is shown in the following tables. Asset information is not reviewed or included with the Company’s internal management reporting. Therefore, the Company has not disclosed asset information for each reportable segment. Revenue by Segment Three Months Ended March 31, (U.S. dollars in thousands) 2023 2022 Nu Skin Americas $ 101,157 $ 123,580 South Korea 70,324 72,133 Mainland China 67,976 124,495 Southeast Asia/Pacific 67,810 90,236 Japan 52,606 61,791 EMEA 47,444 52,968 Hong Kong/Taiwan 34,548 38,494 Other (115 ) 620 Total Nu Skin 441,750 564,317 Rhyz Investments Manufacturing (1) 35,767 40,341 Rhyz other 3,945 241 Total Rhyz Investments 39,712 40,582 Total $ 481,462 $ 604,899 (1) The Rhyz Investments Manufacturing segment had $ 11.8 14.6 Segment Contribution Three Months Ended March 31, (U.S. dollars in thousands) 2023 2022 Nu Skin Americas $ 16,250 $ 21,951 South Korea 23,575 21,998 Mainland China 13,612 28,995 Southeast Asia/Pacific 12,471 20,996 Japan 12,908 14,420 EMEA 3,638 2,622 Hong Kong/Taiwan 7,834 8,086 Nu Skin contribution 90,288 119,068 Rhyz Investments Manufacturing (1,373 ) 3,292 Rhyz other (1,960 ) (1,046 ) Total (3,333 ) 2,246 Total segment contribution 86,955 121,314 Corporate and other (70,891 ) (69,169 ) Operating income 16,064 52,145 Other income (expense), net (1,476 ) (1,453 ) Income before provision for income taxes $ 14,588 $ 50,692 Depreciation and Amortization Three Months Ended March 31, (U.S. dollars in thousands) 2023 2022 Nu Skin Americas $ 66 $ 199 South Korea 453 388 Mainland China 2,775 2,884 Southeast Asia/Pacific 280 381 Japan 1,054 277 EMEA 282 230 Hong Kong/Taiwan 453 691 Total Nu Skin 5,363 5,050 Rhyz Investments Manufacturing 3,424 3,330 Rhyz other 592 592 Total Rhyz Investments 4,016 3,922 Corporate and other 7,604 8,158 Total $ 16,983 $ 17,130 Capital Expenditures Three Months Ended March 31, (U.S. dollars in thousands) 2023 2022 Nu Skin Americas $ 100 $ 42 South Korea 154 362 Mainland China 4,035 4,068 Southeast Asia/Pacific 64 68 Japan 5 — EMEA 119 393 Hong Kong/Taiwan 260 263 Total Nu Skin 4,737 5,196 Rhyz Investments Manufacturing 1,481 1,208 Rhyz other — — Total Rhyz Investments 1,481 1,208 Corporate and other 5,269 3,875 Total $ 11,487 $ 10,279

Commitments and Contingencies

Commitments and Contingencies	3 Months Ended
Commitments and Contingencies	Mar. 31, 2023
Commitments and Contingencies [Abstract]
Commitments and Contingencies	11. Commitments and Contingencies The Company is subject to government regulations pertaining to product formulation, labeling and packaging, product claims and advertising, and the Company’s direct selling system. The Company is also subject to the jurisdiction of numerous foreign tax and customs authorities. Any assertions or determination that either the Company or the Company’s sales force is not in compliance with existing statutes, laws, rules or regulations could have a material adverse effect on the Company’s operations. In addition, in any country or jurisdiction, the adoption of new statutes, laws, rules or regulations or changes in the interpretation of existing statutes, laws, rules or regulations could have a material adverse effect on the Company and its operations. No assurance can be given that the Company’s compliance with applicable statutes, laws, rules and regulations will not be challenged by foreign authorities or that such challenges will not have a material adverse effect on the Company’s financial position, results of operations or cash flows. The Company and its Subsidiaries are defendants in litigation, investigations and other proceedings involving various matters. Management believes that the ultimate liability arising from such claims and contingencies, if any, is not likely to have a material adverse effect on the Company’s consolidated financial condition, results of operations or cash flows. The Company is subject to regular audits by federal, state and foreign tax authorities. These audits may result in additional tax liabilities. The Company believes it has appropriately provided for income taxes for all years. Several factors drive the calculation of its tax reserves. Some of these factors include: (i) the expiration of various statutes of limitations; (ii) changes in tax law and regulations; (iii) issuance of tax rulings; and (iv) settlements with tax authorities. Changes in any of these factors may result in adjustments to the Company’s reserves, which would impact its reported financial results.

Restructuring

Restructuring	3 Months Ended
Restructuring	Mar. 31, 2023
Restructuring [Abstract]
Restructuring	12. Restructuring In 2021, the Company determined to exit the Grow Tech segment, to better align its resources on key strategic initiatives to achieve the future growth objectives and priorities of the core Nu Skin business. The Grow Tech segment was pursuing the commercialization of controlled-environment agriculture for use in the agriculture feed industry. This segment has been operating as part of the Company's Rhyz strategic investment arm. As a result of the restructuring program, the Company recorded a non-cash charge of $38.5 million in 2021, including $9.2 million for impairment of goodwill, $9.0 million for impairment of intangibles, $13.7 million of fixed asset impairments and $6.6 million for inventory write-off, and $20.0 million of cash charges, including $6.5 million for employee severance and $13.5 million for other related cash charges with our restructuring. The restructuring charges were recorded in our previous Grow Tech segment, which has been recast to Corporate & Other. During the first three quarters of 2022, the Company made cash payments totaling $20.0 million, with $11.6 million in the first quarter of 2022. During the fourth quarter of 2022, the Company incurred $5.0 million in incremental charges to be settled in cash associated with the exit activities and legal settlements , , In the third quarter of 2022, the Company adopted a strategic plan to focus resources on the Company’s strategic priorities and optimize future growth and profitability. The global program includes workforce reductions and footprint optimization. The Company estimates total charges under the program will approximate $53.3 million, with $40.8 million in cash charges of severance and lease termination cost and approximately $12.5 million of non-cash charges of impairment of fixed assets, acceleration of depreciation and impairment of other intangibles related to the footprint optimization. The Company expects to substantially complete the program during the first half of 2023. During the back half of 2022, the Company incurred charges to be settled in cash of $20.1 million in severance charges, $7.4 million in lease termination cost, and $5.2 million in other associated cost, and non-cash charges of $8.2 million in fixed asset impairments, $0.9 million in accelerated depreciation and $1.7 million in impairment of other intangibles. During 2022, the Company made cash payments of $21.0 million related to this global program, leaving an ending restructuring accrual of $11.7 million. During the first quarter of 2023, the Company incurred charges to be settled in cash of $4.0 million in severance charges, $1.9 million in lease termination cost, and $2.2 million in other associated cost, and non-cash charges of $1.7 million in accelerated depreciation. During the first quarter of 2023, the Company made cash payments of $7.9 million related to this global program, leaving an ending restructuring accrual of $11.9 million. Restructuring expense by segment (U.S. dollars in thousands) Three Months Ended March 31, 2023 Nu Skin Americas $ 918 South Korea 422 Mainland China 1,352 Southeast Asia/Pacific 131 Japan 1,515 EMEA (113 ) Hong Kong/Taiwan (201 ) Total Nu Skin 4,024 Rhyz Investments Manufacturing 13 Rhyz other — Total Rhyz Investments 13 Corporate and other 5,750 Total $ 9,787

Subsequent Event

Subsequent Event	3 Months Ended
Subsequent Event	Mar. 31, 2023
Subsequent Event [Abstract]
Subsequent Event	13. Subsequent Events On April 29, 2023, the Company acquired 60 percent of LifeDNA, Inc. (“LifeDNA”), a DNA assessment company. Consideration paid included $4.0 million of cash, along with the conversion of a previous $3.0 million Simple Agreement for Future Equity (“SAFE”), and a $0.2 million convertible note. Due to the timing of the acquisition, the initial accounting for the acquisition is incomplete. As such, the Company is not able to disclose certain information relating to the acquisition, including the preliminary fair value of assets acquired and liabilities assumed.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	3 Months Ended
Summary of Significant Accounting Policies (Policies)	Mar. 31, 2023
Summary of Significant Accounting Policies [Abstract]
Basis of Accounting	The accompanying unaudited consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”)
Consolidation	The unaudited consolidated financial statements include the accounts of the Company and its Subsidiaries. All significant intercompany accounts and transactions are eliminated in consolidation.
Accounting Pronouncements	Accounting Pronouncements In March 2020 Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting, Company’s debt transitioned to the Secured Overnight Financing Rate (“SOFR”)
Inventory	Inventory Inventories consist of the following (U.S. dollars in thousands): March 31, 2023 December 31, 2022 Raw materials $ 175,579 $ 163,797 Finished goods 190,958 182,386 Total Inventory, net $ 366,537 $ 346,183
Revenue Recognition	Revenue Recognition Contract Liabilities – Customer Loyalty Programs Contract liabilities, recorded as deferred revenue within the accrued expenses line in the consolidated balance sheets, include loyalty point program deferrals with certain customers which are accounted for as a reduction in the transaction price and are generally recognized as points are redeemed for additional products. The balance of deferred revenue related to contract liabilities as of March and December was and , respectively. The contract liabilities impact to revenue for the -month periods ended March and was an increase of

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Tables)	3 Months Ended
Summary of Significant Accounting Policies (Tables)	Mar. 31, 2023
Summary of Significant Accounting Policies [Abstract]
Inventories	Inventories consist of the following (U.S. dollars in thousands): March 31, 2023 December 31, 2022 Raw materials $ 175,579 $ 163,797 Finished goods 190,958 182,386 Total Inventory, net $ 366,537 $ 346,183

Goodwill (Tables)

Goodwill (Tables)	3 Months Ended
Goodwill (Tables)	Mar. 31, 2023
Goodwill [Abstract]
Goodwill	The following table presents goodwill allocated to the Company’s reportable segments for the periods ended and December 31, 2022 (U.S. dollars in thousands): March 31, 2023 December 31, 2022 Nu Skin Americas $ 9,449 $ 9,449 South Korea 29,261 29,261 Mainland China 32,179 32,179 Southeast Asia/Pacific 18,537 18,537 Japan 16,019 16,019 EMEA 2,875 2,875 Hong Kong/Taiwan 6,634 6,634 Rhyz Investments Manufacturing 78,875 78,875 Rhyz Other 12,603 12,603 Total $ 206,432 $ 206,432

Debt (Tables)

Debt (Tables)	3 Months Ended
Debt (Tables)	Mar. 31, 2023
Debt [Abstract]
Debt Facilities	The following table summarizes the Company’s debt facilities as of March 31, 2023 and December 31, 2022: Facility or Arrangement Original Principal Amount Balance as of March 31, 2023 (1)(2) Balance as of December 31, 2022 (1)(2) Interest Rate Repayment Terms Credit Agreement term loan facility $400.0 million $392.5 million $395.0 million Variable 21% of the principal amount is payable Credit Agreement revolving credit facility $30.0 million $10.0 million Variable Revolving line of credit expires June 14, 2027. (1) As of March 31, 2023 and December 31, 2022, the current portion of the Company’s debt (i.e., becoming due in the next 12 months) included $17.5 million and $15.0 million, respectively, of the balance of its term loan under the Credit Agreement. (2) The carrying value of the debt reflects the amounts stated in the above table, less debt issuance costs of $2.4 million and $ million as of and December 31, 2022, respectively, related to the Credit Agreement, which are not reflected in this table.

Leases (Tables)

Leases (Tables)	3 Months Ended
Leases (Tables)	Mar. 31, 2023
Leases [Abstract]
Components of Lease Expense	The components of lease expense were as follows (U.S. dollars in thousands): Three Months Ended March 31 2023 2022 Operating lease expense Operating lease cost $ 8,161 $ 10,439 Variable lease cost 1,075 1,157 Short-term lease cost — 30 Finance lease expense Amortization of right-of-use assets 1,000 556 Interest on lease liabilities 134 66 Total lease expense $ 10,370 $ 12,248
Supplemental Cash Flow Information Related to Leases	Supplemental cash flow information related to leases was as follows (U.S. dollars in thousands): Three March 31 2023 2022 Operating cash outflow from operating leases $ 8,150 $ 10,405 Operating cash outflow from finance leases $ 132 $ 68 Financing cash outflow from finance leases $ 912 $ 476 Right-of-use assets obtained in exchange for operating lease obligations $ 7,981 $ 23,730 Right-of-use assets obtained in exchange for finance lease obligations $ 520 $ —
Maturities of Lease Liabilities	Maturities of lease liabilities were as follows (U.S. dollars in thousands): Year Ending December 31 Operating Leases Finance Leases 2023 $ 18,542 $ 2,875 2024 20,249 3,474 2025 14,916 3,400 2026 10,241 3,305 2027 7,885 2,953 Thereafter 43,851 — Total 115,684 16,007 Less: Finance charges 15,200 1,269 Total principal liability $ 100,484 $ 14,738

Fair Value and Equity Investm_2

Fair Value and Equity Investments (Tables)	3 Months Ended
Fair Value and Equity Investments (Tables)	Mar. 31, 2023
Fair Value and Equity Investments [Abstract]
Assets and Liabilities Measured at Fair Value on a Recurring Basis	The following tables present the fair value hierarchy for those assets and liabilities measured at fair value on a recurring basis (U.S. dollars in thousands): Fair Value at March 31, 2023 Level 1 Level 2 Level 3 Total Financial assets (liabilities): Cash equivalents and current investments $ 46,632 $ — $ — $ 46,632 Derivative financial instruments asset — 16,731 — 16,731 Life insurance contracts — — 42,053 42,053 Contingent consideration — — (6,271 ) (6,271 ) Total $ 46,632 $ 16,731 $ 35,782 $ 99,145 Fair Value at December 31, 2022 Level 1 Level 2 Level 3 Total Financial assets (liabilities): Cash equivalents and current investments $ 55,356 $ — $ — $ 55,356 Derivative financial instruments asset — 19,738 — 19,738 Life insurance contracts — — 40,055 40,055 Contingent consideration — — (6,364 ) (6,364 ) Total $ 55,356 $ 19,738 $ 33,691 $ 108,785
Changes in Fair Value of Level 3 Life Insurance Contracts	The following table provides a summary of changes in fair value of the Company’s Level 3 life insurance contracts (U.S. dollars in thousands): 2023 2022 Beginning balance at January 1 $ 40,055 $ 49,851 Actual return on plan assets 1,998 (3,401 ) Ending balance at March 31 $ 42,053 $ 46,450
Changes in Fair Value of Level 3 Contingent Consideration	The following table provides a summary of changes in fair value of the Company’s Level 3 contingent consideration (U.S. dollars in thousands): 2023 2022 Beginning balance at January 1 $ (6,364 ) $ (10,341 ) Changes in fair value of contingent consideration 93 115 Ending balance at March 31 $ (6,271 ) $ (10,226 )

Derivatives and Hedging Activ_2

Derivatives and Hedging Activities (Tables)	3 Months Ended
Derivatives and Hedging Activities (Tables)	Mar. 31, 2023
Derivatives and Hedging Activities [Abstract]
Fair Value of Derivative Instruments on the Balance Sheet	The table below presents the fair value of the Company’s derivative financial instruments as well as their classification on the Balance Sheet: Fair Values of Derivative Instruments Derivatives in Cash flow Hedging Relationships: Balance Sheet Location March 31, 2023 December 31, 2022 Interest Rate Swap - Asset Prepaid expenses and other $ 8,814 $ 9,156 Interest Rate Swap - Asset Other assets $ 7,917 $ 10,582
Effect of Cash Flow Hedge Accounting on Accumulated Other Comprehensive Loss	The tables below present the effect of cash flow hedge accounting on Accumulated Other Comprehensive Loss. Amount of Gain (Loss) Recognized in OCI on Derivatives Three Months Ended Derivatives in Cash flow March 31, Hedging Relationships: 2023 2022 Interest Rate Swaps $ (810 ) $ 8,057 Amount of Gain (Loss) Reclassified from Accumulated Other Comprehensive Loss into Income Three Months Ended Derivatives in Cash flow Income Statement March 31, Hedging Relationships: Location 2023 2022 Interest Rate Swaps Other income (expense), net $ 2,197 $ (18 )

Segment Information (Tables)

Segment Information (Tables)	3 Months Ended
Segment Information (Tables)	Mar. 31, 2023
Segment Information [Abstract]
Revenue by Segment	Revenue by Segment Three Months Ended March 31, (U.S. dollars in thousands) 2023 2022 Nu Skin Americas $ 101,157 $ 123,580 South Korea 70,324 72,133 Mainland China 67,976 124,495 Southeast Asia/Pacific 67,810 90,236 Japan 52,606 61,791 EMEA 47,444 52,968 Hong Kong/Taiwan 34,548 38,494 Other (115 ) 620 Total Nu Skin 441,750 564,317 Rhyz Investments Manufacturing (1) 35,767 40,341 Rhyz other 3,945 241 Total Rhyz Investments 39,712 40,582 Total $ 481,462 $ 604,899 (1) The Rhyz Investments Manufacturing segment had $ 11.8 14.6
Segment Contribution	Segment Contribution Three Months Ended March 31, (U.S. dollars in thousands) 2023 2022 Nu Skin Americas $ 16,250 $ 21,951 South Korea 23,575 21,998 Mainland China 13,612 28,995 Southeast Asia/Pacific 12,471 20,996 Japan 12,908 14,420 EMEA 3,638 2,622 Hong Kong/Taiwan 7,834 8,086 Nu Skin contribution 90,288 119,068 Rhyz Investments Manufacturing (1,373 ) 3,292 Rhyz other (1,960 ) (1,046 ) Total (3,333 ) 2,246 Total segment contribution 86,955 121,314 Corporate and other (70,891 ) (69,169 ) Operating income 16,064 52,145 Other income (expense), net (1,476 ) (1,453 ) Income before provision for income taxes $ 14,588 $ 50,692
Depreciation and Amortization and Capital Expenditures	Depreciation and Amortization Three Months Ended March 31, (U.S. dollars in thousands) 2023 2022 Nu Skin Americas $ 66 $ 199 South Korea 453 388 Mainland China 2,775 2,884 Southeast Asia/Pacific 280 381 Japan 1,054 277 EMEA 282 230 Hong Kong/Taiwan 453 691 Total Nu Skin 5,363 5,050 Rhyz Investments Manufacturing 3,424 3,330 Rhyz other 592 592 Total Rhyz Investments 4,016 3,922 Corporate and other 7,604 8,158 Total $ 16,983 $ 17,130 Capital Expenditures Three Months Ended March 31, (U.S. dollars in thousands) 2023 2022 Nu Skin Americas $ 100 $ 42 South Korea 154 362 Mainland China 4,035 4,068 Southeast Asia/Pacific 64 68 Japan 5 — EMEA 119 393 Hong Kong/Taiwan 260 263 Total Nu Skin 4,737 5,196 Rhyz Investments Manufacturing 1,481 1,208 Rhyz other — — Total Rhyz Investments 1,481 1,208 Corporate and other 5,269 3,875 Total $ 11,487 $ 10,279

Restructuring (Tables)

Restructuring (Tables)	3 Months Ended
Restructuring (Tables)	Mar. 31, 2023
Restructuring [Abstract]
Restructuring Expense by Segment	Restructuring expense by segment (U.S. dollars in thousands) Three Months Ended March 31, 2023 Nu Skin Americas $ 918 South Korea 422 Mainland China 1,352 Southeast Asia/Pacific 131 Japan 1,515 EMEA (113 ) Hong Kong/Taiwan (201 ) Total Nu Skin 4,024 Rhyz Investments Manufacturing 13 Rhyz other — Total Rhyz Investments 13 Corporate and other 5,750 Total $ 9,787

The Company (Details)

The Company (Details)	3 Months Ended
The Company (Details)	Mar. 31, 2023 Segment
The Company [Abstract]
Number of reportable segments	9
Number of geographic segments	7
Number of Rhyz Investments segments	2

Summary of Significant Accoun_4

Summary of Significant Accounting Policies, Inventory (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Inventories [Abstract]
Raw materials	$ 175,579	$ 163,797
Finished goods	190,958	182,386
Total Inventory, net	$ 366,537	$ 346,183

Summary of Significant Accoun_5

Summary of Significant Accounting Policies, Revenue Recognition (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022
Contract Liabilities - Customer Loyalty Programs [Abstract]
Contract liabilities for customer loyalty programs	$ 17.4		$ 18.7
Contract liabilities, increase to revenue	$ 1.3	$ 1.2

Goodwill (Details)

Goodwill (Details) - USD ($) $ in Thousands	12 Months Ended
Goodwill (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Mar. 31, 2023	Sep. 30, 2022
Goodwill [Abstract]
Impairment of goodwill	$ 0
Goodwill	206,432	$ 206,432
Americas [Member]
Goodwill [Abstract]
Goodwill	9,449	9,449
South Korea [Member]
Goodwill [Abstract]
Goodwill	29,261	29,261
Mainland China [Member]
Goodwill [Abstract]
Goodwill	32,179	32,179
Southeast Asia/Pacific [Member]
Goodwill [Abstract]
Goodwill	18,537	18,537
Japan [Member]
Goodwill [Abstract]
Goodwill	16,019	16,019
EMEA [Member]
Goodwill [Abstract]
Goodwill	2,875	2,875
Hong Kong/Taiwan [Member]
Goodwill [Abstract]
Goodwill	6,634	6,634
Manufacturing [Member]
Goodwill [Abstract]
Goodwill	78,875	78,875
Rhyz Other [Member]
Goodwill [Abstract]
Goodwill	$ 12,603	$ 12,603
Manufacturing Reporting Unit [Member]
Goodwill [Abstract]
Percentage of fair value in excess of carrying amount			8%

Debt, Credit Agreement (Details

Debt, Credit Agreement (Details) - USD ($) $ in Millions	3 Months Ended
Debt, Credit Agreement (Details) - USD ($) $ in Millions	Mar. 31, 2023	Jun. 14, 2022
Credit Agreement [Member]
Debt [Abstract]
Percentage of capital stock of certain foreign subsidiaries pledged as collateral	65%
Credit Agreement [Member] \| Minimum [Member]
Debt [Abstract]
Commitment fee percentage payable on unused portion	0.175%
Consolidated interest coverage ratio	3
Credit Agreement [Member] \| Maximum [Member]
Debt [Abstract]
Commitment fee percentage payable on unused portion	0.30%
Consolidated leverage ratio	2.75
Term Loan Facility [Member]
Debt [Abstract]
Original principal amount	$ 400	$ 400
Term of loan	5 years
Term Loan Facility [Member] \| First Year [Member]
Debt [Abstract]
Annual amortization percentage	2.50%
Term Loan Facility [Member] \| Second Year [Member]
Debt [Abstract]
Annual amortization percentage	5%
Term Loan Facility [Member] \| Third Year [Member]
Debt [Abstract]
Annual amortization percentage	5%
Term Loan Facility [Member] \| Fourth Year [Member]
Debt [Abstract]
Annual amortization percentage	5%
Term Loan Facility [Member] \| Fifth Year [Member]
Debt [Abstract]
Annual amortization percentage	5%
Revolving Credit Facility [Member]
Debt [Abstract]
Borrowing capacity		$ 500
Term of loan	5 years

Debt, Debt Facilities (Details)

Debt, Debt Facilities (Details) - USD ($) $ in Thousands		3 Months Ended
Debt, Debt Facilities (Details) - USD ($) $ in Thousands		Mar. 31, 2023	Dec. 31, 2022	Jun. 14, 2022
Debt [Abstract]
Term of variable rate		30 days
Current portion of long-term debt		$ 47,500	$ 25,000
Credit Agreement [Member]
Debt [Abstract]
Unamortized debt issuance costs		2,400	2,500
Credit Agreement Term Loan Facility [Member]
Debt [Abstract]
Original principal amount		400,000		$ 400,000
Balance	[1],[2]	$ 392,500	395,000
Interest rate		Variable 30 day: 6.91%
Interest rate		6.91%
Term of variable rate		30 days
Repayment terms		21% of the principal amount is payable in increasing quarterly installments over a five-year period that began on September 30, 2022, with the remainder payable at the end of the five-year term.
Percentage of principal payable in installments		21%
Term of loan		5 years
Current portion of long-term debt		$ 17,500	15,000
Credit Agreement Revolving Credit Facility [Member]
Debt [Abstract]
Balance	[1],[2]	$ 30,000	$ 10,000
Interest rate		Variable 30 day: 6.83%
Interest rate		6.83%
Term of variable rate		30 days
Repayment terms		Revolving line of credit expires June 14, 2027.
Term of loan		5 years

[1]As of March 31, 2023 and December 31, 2022, the current portion of the Company’s debt (i.e., becoming due in the next 12 months) included $17.5 million and $15.0 million, respectively, of the balance of its term loan under the Credit Agreement.[2]The carrying value of the debt reflects the amounts stated in the above table, less debt issuance costs of $2.4 million and $ million as of and December 31, 2022, respectively, related to the Credit Agreement, which are not reflected in this table.

Leases (Details)

Leases (Details) - USD ($) $ in Thousands	3 Months Ended
Leases (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Mar. 31, 2022
Leases [Abstract]
Weighted average remaining lease term for operating leases	8 years 9 months 18 days
Weighted average remaining lease term for finance leases	4 years 4 months 24 days
Weighted average discount rate for operating leases	3.30%
Weighted average discount rate for finance leases	3.60%
Operating Lease Expense [Abstract]
Operating lease cost	$ 8,161	$ 10,439
Variable lease cost	1,075	1,157
Short-term lease cost	0	30
Finance Lease Expense [Abstract]
Amortization of right-of-use assets	1,000	556
Interest on lease liabilities	134	66
Total lease expense	10,370	12,248
Supplemental Cash Flow Information Related to Leases [Abstract]
Operating cash outflow from operating leases	8,150	10,405
Operating cash outflow from finance leases	132	68
Financing cash outflow from finance leases	912	476
Right-of-use assets obtained in exchange for operating lease obligations	7,981	23,730
Right-of-use assets obtained in exchange for finance lease obligations	520	$ 0
Maturities of Operating Lease Liabilities [Abstract]
2023	18,542
2024	20,249
2025	14,916
2026	10,241
2027	7,885
Thereafter	43,851
Total	115,684
Less: Finance charges	15,200
Total principal liability	100,484
Maturities of Financing Lease Liabilities [Abstract]
2023	2,875
2024	3,474
2025	3,400
2026	3,305
2027	2,953
Thereafter	0
Total	16,007
Less: Finance charges	1,269
Total principal liability	14,738
Additional lease liabilities not yet commenced	$ 1,300

Capital Stock, Net Income per S

Capital Stock, Net Income per Share (Details) - shares shares in Millions	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Stock Options [Member]
Net Income per Share [Abstract]
Anti-dilutive shares excluded from calculation of diluted earnings per share (in shares)	0.1	0.1

Capital Stock, Dividends (Detai

Capital Stock, Dividends (Details) - USD ($) $ / shares in Units, $ in Thousands	1 Months Ended		3 Months Ended
	May 31, 2023	Feb. 28, 2023	Mar. 31, 2023	Mar. 31, 2022
Dividends per Share [Abstract]
Payment of cash dividends			$ 19,392	$ 19,293
Dividend Declared 2023-Q1 [Member]
Dividends per Share [Abstract]
Dividend payable, date declared			2023-02
Dividend payable per share (in dollars per share)		$ 0.39
Payment of cash dividends		$ 19,400
Dividend payable, date paid			Mar. 08, 2023
Dividend payable, date of record			Feb. 27, 2023
Dividend Declared 2023-Q2 [Member] \| Subsequent Event [Member]
Dividends per Share [Abstract]
Dividend payable, date declared	2023-04
Dividend payable per share (in dollars per share)	$ 0.39
Dividend payable, date paid	Jun. 07, 2023
Dividend payable, date of record	May 26, 2023

Capital Stock, Repurchase of Co

Capital Stock, Repurchase of Common Stock (Details) - USD ($) $ in Thousands, shares in Millions	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Repurchases of Common Stock [Abstract]
Class A common stock repurchased	$ 0	$ 10,006
Amount available for repurchases	$ 175,400
Treasury Stock [Member]
Repurchases of Common Stock [Abstract]
Class A common stock repurchased (in shares)	0	0.2
Class A common stock repurchased	$ 0	$ 10,006

Fair Value and Equity Investm_3

Fair Value and Equity Investments, Fair Value (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022
Fair Value and Equity Investments [Abstract]
Term of variable rate	30 days
Contingent Consideration [Member]
Changes in Fair Value of Level 3 Contingent Consideration [Roll Forward]
Beginning balance	$ (6,364)	$ (10,341)
Changes in fair value of contingent consideration	93	115
Ending balance	(6,271)	(10,226)
Fair Value on a Recurring Basis [Member]
Financial Assets (Liabilities) [Abstract]
Cash equivalents and current investments	46,632		$ 55,356
Derivative financial instruments asset	16,731		19,738
Life insurance contracts	42,053		40,055
Contingent consideration	(6,271)		(6,364)
Financial assets (liabilities)	99,145		108,785
Fair Value on a Recurring Basis [Member] \| Level 1 [Member]
Financial Assets (Liabilities) [Abstract]
Cash equivalents and current investments	46,632		55,356
Derivative financial instruments asset	0		0
Life insurance contracts	0		0
Contingent consideration	0		0
Financial assets (liabilities)	46,632		55,356
Fair Value on a Recurring Basis [Member] \| Level 2 [Member]
Financial Assets (Liabilities) [Abstract]
Cash equivalents and current investments	0		0
Derivative financial instruments asset	16,731		19,738
Life insurance contracts	0		0
Contingent consideration	0		0
Financial assets (liabilities)	16,731		19,738
Fair Value on a Recurring Basis [Member] \| Level 3 [Member]
Financial Assets (Liabilities) [Abstract]
Cash equivalents and current investments	0		0
Derivative financial instruments asset	0		0
Life insurance contracts	42,053		40,055
Contingent consideration	(6,271)		(6,364)
Financial assets (liabilities)	35,782		$ 33,691
Life Insurance Contracts [Member]
Changes in Fair Value of Level 3 Marketable Securities [Roll Forward]
Beginning balance	40,055	49,851
Actual return on plan assets	1,998	(3,401)
Ending balance	$ 42,053	$ 46,450

Fair Value and Equity Investm_4

Fair Value and Equity Investments, Equity Investments (Details) - Equity Securities [Member] - USD ($) $ in Millions	3 Months Ended
	Sep. 30, 2021	Mar. 31, 2023	Dec. 31, 2022
Equity Securities without Readily Determinable Fair Value [Line Items]
Carrying amount of equity securities without readily determinable fair values		$ 28.1	$ 28.1
Other Income (Expense), Net [Member]
Equity Securities without Readily Determinable Fair Value [Line Items]
Upward fair value adjustments on equity securities	$ 18.1

Income Taxes (Details)

Income Taxes (Details) - USD ($) $ in Thousands	3 Months Ended
Income Taxes (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022
Income Taxes [Abstract]
Provision for income taxes	$ 3,212	$ 11,976
Effective tax rate	22%	23.60%
Net deferred tax assets	$ 91,800		$ 89,300
Undistributed earnings of non-U.S. subsidiaries			60,000
Incremental taxes if undistributed earnings on non-U.S. subsidiaries were repatriated			$ 6,000
Minimum [Member]
Income Taxes [Abstract]
Increase in unrecognized tax benefits within the next 12 months that is reasonably possible	3,000
Maximum [Member]
Income Taxes [Abstract]
Increase in unrecognized tax benefits within the next 12 months that is reasonably possible	$ 4,000
Foreign Jurisdictions [Member] \| Minimum [Member]
Income Taxes [Abstract]
Statute of limitations related to income tax examinations	3 years
Foreign Jurisdictions [Member] \| Maximum [Member]
Income Taxes [Abstract]
Statute of limitations related to income tax examinations	10 years

Derivatives and Hedging Activ_3

Derivatives and Hedging Activities, Fair Value of Derivative Instruments on the Balance Sheet (Details) $ in Thousands	3 Months Ended
	Mar. 31, 2023 USD ($) Derivatives	Dec. 31, 2022 USD ($) Derivatives
Derivatives and Hedging Activities [Abstract]
Loss to be reclassified to interest expense during next twelve months	$ (8,800)
Number of outstanding derivatives held \| Derivatives	4	4
Notional amount	$ 200,000	$ 200,000
Interest Rate Swaps [Member] \| Designated as Hedging Instrument [Member] \| Prepaid Expenses and Other [Member]
Derivatives and Hedging Activities [Abstract]
Fair value, asset	8,814	9,156
Interest Rate Swaps [Member] \| Designated as Hedging Instrument [Member] \| Other Assets [Member]
Derivatives and Hedging Activities [Abstract]
Fair value, asset	$ 7,917	$ 10,582

Derivatives and Hedging Activ_4

Derivatives and Hedging Activities, Effect of Cash Flow Hedge Accounting on Accumulated Other Comprehensive Loss (Details) - Interest Rate Swaps [Member] - Designated as Hedging Instrument [Member] - Cash Flow Hedges [Member] - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Other Income (Expense), Net [Member]
Derivatives and Hedging Activities [Abstract]
Gain (loss) reclassified from accumulated other comprehensive loss into income	$ 2,197	$ (18)
Other Comprehensive Income (Loss) [Member]
Derivatives and Hedging Activities [Abstract]
Gain (loss) recognized in OCI	$ (810)	$ 8,057

Segment Information, Revenue by

Segment Information, Revenue by Segment (Details) $ in Thousands		3 Months Ended
		Mar. 31, 2023 USD ($) Segment	Mar. 31, 2022 USD ($)
Segment Information [Abstract]
Number of reportable segments \| Segment		9
Number of geographic segments \| Segment		7
Number of Rhyz Investments segments \| Segment		2
Revenue by Segment [Abstract]
Revenue		$ 481,462	$ 604,899
Other [Member]
Revenue by Segment [Abstract]
Revenue		(115)	620
Operating Segment [Member] \| Nu Skin [Member]
Revenue by Segment [Abstract]
Revenue		441,750	564,317
Operating Segment [Member] \| Americas [Member]
Revenue by Segment [Abstract]
Revenue		101,157	123,580
Operating Segment [Member] \| South Korea [Member]
Revenue by Segment [Abstract]
Revenue		70,324	72,133
Operating Segment [Member] \| Mainland China [Member]
Revenue by Segment [Abstract]
Revenue		67,976	124,495
Operating Segment [Member] \| Southeast Asia/Pacific [Member]
Revenue by Segment [Abstract]
Revenue		67,810	90,236
Operating Segment [Member] \| Japan [Member]
Revenue by Segment [Abstract]
Revenue		52,606	61,791
Operating Segment [Member] \| EMEA [Member]
Revenue by Segment [Abstract]
Revenue		47,444	52,968
Operating Segment [Member] \| Hong Kong/Taiwan [Member]
Revenue by Segment [Abstract]
Revenue		34,548	38,494
Operating Segment [Member] \| Rhyz Investments [Member]
Revenue by Segment [Abstract]
Revenue		39,712	40,582
Operating Segment [Member] \| Manufacturing [Member]
Revenue by Segment [Abstract]
Revenue	[1]	35,767	40,341
Operating Segment [Member] \| Rhyz Other [Member]
Revenue by Segment [Abstract]
Revenue		3,945	241
Intersegment [Member] \| Manufacturing [Member]
Revenue by Segment [Abstract]
Revenue		$ 11,800	$ 14,600

[1]The Rhyz Investments Manufacturing segment had $ 11.8 14.6

Segment Information, Segment Co

Segment Information, Segment Contribution (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Segment Contribution [Abstract]
Operating income	$ 16,064	$ 52,145
Other income (expense), net	(1,476)	(1,453)
Income before provision for income taxes	14,588	50,692
Operating Segment [Member]
Segment Contribution [Abstract]
Operating income	86,955	121,314
Operating Segment [Member] \| Nu Skin [Member]
Segment Contribution [Abstract]
Operating income	90,288	119,068
Operating Segment [Member] \| Americas [Member]
Segment Contribution [Abstract]
Operating income	16,250	21,951
Operating Segment [Member] \| South Korea [Member]
Segment Contribution [Abstract]
Operating income	23,575	21,998
Operating Segment [Member] \| Mainland China [Member]
Segment Contribution [Abstract]
Operating income	13,612	28,995
Operating Segment [Member] \| Southeast Asia/Pacific [Member]
Segment Contribution [Abstract]
Operating income	12,471	20,996
Operating Segment [Member] \| Japan [Member]
Segment Contribution [Abstract]
Operating income	12,908	14,420
Operating Segment [Member] \| EMEA [Member]
Segment Contribution [Abstract]
Operating income	3,638	2,622
Operating Segment [Member] \| Hong Kong/Taiwan [Member]
Segment Contribution [Abstract]
Operating income	7,834	8,086
Operating Segment [Member] \| Rhyz Investments [Member]
Segment Contribution [Abstract]
Operating income	(3,333)	2,246
Operating Segment [Member] \| Manufacturing [Member]
Segment Contribution [Abstract]
Operating income	(1,373)	3,292
Operating Segment [Member] \| Rhyz Other [Member]
Segment Contribution [Abstract]
Operating income	(1,960)	(1,046)
Corporate and Other [Member]
Segment Contribution [Abstract]
Operating income	$ (70,891)	$ (69,169)

Segment Information, Depreciati

Segment Information, Depreciation and Amortization and Capital Expenditures (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Summarized Financial Information [Abstract]
Depreciation and amortization	$ 16,983	$ 17,130
Capital expenditures	11,487	10,279
Operating Segments [Member] \| Nu Skin [Member]
Summarized Financial Information [Abstract]
Depreciation and amortization	5,363	5,050
Capital expenditures	4,737	5,196
Operating Segments [Member] \| Americas [Member]
Summarized Financial Information [Abstract]
Depreciation and amortization	66	199
Capital expenditures	100	42
Operating Segments [Member] \| South Korea [Member]
Summarized Financial Information [Abstract]
Depreciation and amortization	453	388
Capital expenditures	154	362
Operating Segments [Member] \| Mainland China [Member]
Summarized Financial Information [Abstract]
Depreciation and amortization	2,775	2,884
Capital expenditures	4,035	4,068
Operating Segments [Member] \| Southeast Asia/Pacific [Member]
Summarized Financial Information [Abstract]
Depreciation and amortization	280	381
Capital expenditures	64	68
Operating Segments [Member] \| Japan [Member]
Summarized Financial Information [Abstract]
Depreciation and amortization	1,054	277
Capital expenditures	5	0
Operating Segments [Member] \| EMEA [Member]
Summarized Financial Information [Abstract]
Depreciation and amortization	282	230
Capital expenditures	119	393
Operating Segments [Member] \| Hong Kong/Taiwan [Member]
Summarized Financial Information [Abstract]
Depreciation and amortization	453	691
Capital expenditures	260	263
Operating Segments [Member] \| Rhyz Investments [Member]
Summarized Financial Information [Abstract]
Depreciation and amortization	4,016	3,922
Capital expenditures	1,481	1,208
Operating Segments [Member] \| Manufacturing [Member]
Summarized Financial Information [Abstract]
Depreciation and amortization	3,424	3,330
Capital expenditures	1,481	1,208
Operating Segments [Member] \| Rhyz Other [Member]
Summarized Financial Information [Abstract]
Depreciation and amortization	592	592
Capital expenditures	0	0
Corporate and Other [Member]
Summarized Financial Information [Abstract]
Depreciation and amortization	7,604	8,158
Capital expenditures	$ 5,269	$ 3,875

Restructuring, Exit Grow Tech S

Restructuring, Exit Grow Tech Segment (Details) - USD ($) $ in Thousands	3 Months Ended			9 Months Ended	12 Months Ended
	Mar. 31, 2023	Dec. 31, 2022	Mar. 31, 2022	Sep. 30, 2022	Dec. 31, 2022	Dec. 31, 2021
Restructuring [Abstract]
Non-cash impairment charges	$ 9,787		$ 0
Impairment of goodwill					$ 0
Exit Grow Tech Segment [Member]
Restructuring [Abstract]
Non-cash impairment charges						$ 38,500
Impairment of goodwill						9,200
Impairment of intangible assets						9,000
Impairment of fixed assets						13,700
Inventory write-off						6,600
Cash charges associated with restructuring						20,000
Employee severance						6,500
Other related restructuring charges		$ 5,000				$ 13,500
Cash payments	5,000		$ 11,600	$ 20,000
Ending restructuring accrual	$ 0	$ 5,000			$ 5,000

Restructuring, Strategic Plan (

Restructuring, Strategic Plan (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended	12 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022	Dec. 31, 2022	Sep. 30, 2022
Restructuring [Abstract]
Restructuring expenses	$ 9,787	$ 0
Strategic Plan [Member]
Restructuring [Abstract]
Estimated restructuring costs					$ 53,300
Severance charges	4,000		$ 20,100
Lease termination cost	1,900		7,400
Other associated restructuring charges	2,200		5,200
Impairment of fixed assets	1,700		8,200
Accelerated depreciation			900
Impairment of other intangible assets			1,700
Cash payments	7,900			$ 21,000
Ending restructuring accrual	11,900		$ 11,700	$ 11,700
Restructuring expenses	9,787
Strategic Plan [Member] \| Operating Segment [Member] \| Nu Skin [Member]
Restructuring [Abstract]
Restructuring expenses	4,024
Strategic Plan [Member] \| Operating Segment [Member] \| Americas [Member]
Restructuring [Abstract]
Restructuring expenses	918
Strategic Plan [Member] \| Operating Segment [Member] \| South Korea [Member]
Restructuring [Abstract]
Restructuring expenses	422
Strategic Plan [Member] \| Operating Segment [Member] \| Mainland China [Member]
Restructuring [Abstract]
Restructuring expenses	1,352
Strategic Plan [Member] \| Operating Segment [Member] \| Southeast Asia/Pacific [Member]
Restructuring [Abstract]
Restructuring expenses	131
Strategic Plan [Member] \| Operating Segment [Member] \| Japan [Member]
Restructuring [Abstract]
Restructuring expenses	1,515
Strategic Plan [Member] \| Operating Segment [Member] \| EMEA [Member]
Restructuring [Abstract]
Restructuring expenses	(113)
Strategic Plan [Member] \| Operating Segment [Member] \| Hong Kong/Taiwan [Member]
Restructuring [Abstract]
Restructuring expenses	(201)
Strategic Plan [Member] \| Operating Segment [Member] \| Rhyz Investments [Member]
Restructuring [Abstract]
Restructuring expenses	13
Strategic Plan [Member] \| Operating Segment [Member] \| Manufacturing [Member]
Restructuring [Abstract]
Restructuring expenses	13
Strategic Plan [Member] \| Operating Segment [Member] \| Rhyz Other [Member]
Restructuring [Abstract]
Restructuring expenses	0
Strategic Plan [Member] \| Corporate and Other [Member]
Restructuring [Abstract]
Restructuring expenses	$ 5,750
Strategic Plan [Member] \| Severance and Lease Termination [Member]
Restructuring [Abstract]
Estimated restructuring costs					40,800
Strategic Plan [Member] \| Impairment of Fixed Assets and Other Intangibles Related to Footprint Optimization [Member]
Restructuring [Abstract]
Estimated restructuring costs					$ 12,500

Subsequent Event (Details)

Subsequent Event (Details) - Subsequent Event [Member] - LifeDNA [Member] $ in Millions	Apr. 29, 2023 USD ($)
Subsequent Event [Abstract]
Percentage acquired	60%
Consideration paid, cash	$ 4
Consideration paid, conversion of previous SAFE	3
Consideration paid, convertible note	$ 0.2